BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 524688)

  • 1. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
    Koshkin VM; Adil'khanov SG; Antonova NIu
    Vestn Khir Im I I Grek; 1979 Dec; 123(12):56-60. PubMed ID: 524688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some mechanisms of papaverine and trental action in patients with acute arterial obstruction].
    Sergeeva NA; Terekhova TV; Koshkin VM; Adil'khanov SG; Sapozhnikov VA
    Vestn Khir Im I I Grek; 1980 May; 124(5):10-3. PubMed ID: 6252675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correction of disorders of peripheral circulation with trental in children in the postoperative period].
    Doletskiĭ AS; Dallakian NO; Aksel'rov AM; Nazarova NB; Sokolova VA
    Anesteziol Reanimatol; 1985; (4):56-8. PubMed ID: 4061952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction].
    Zatevakhin II; Koshkin VM; Shestakov VA; Il'in SG; Adil'khanov SG
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):40-3. PubMed ID: 523450
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M
    Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pentoxifylline and papaverine on tissue perfusion during arterial surgery.
    Niinikoski J; Vänttinen E
    Acta Chir Scand; 1988; 154(11-12):641-5. PubMed ID: 3232482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
    von Westphalen JG
    MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic mechanisms of the action of trental (pentoxifylline) on the microcirculation)].
    Vinnitskiĭ LI
    Patol Fiziol Eksp Ter; 1979; (6):69-70. PubMed ID: 232259
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a course of pentoxifylline (trental) treatment on microcirculatory and central hemodynamic functions in chronic ischemic heart disease patients].
    Atroshchenko ES
    Ter Arkh; 1985; 57(1):43-6. PubMed ID: 3983842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders].
    Feine-Haake G
    Fortschr Med; 1977 Jan; 95(1):48-51. PubMed ID: 401759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Völker D
    Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
    Tonak J; Knecht H; Groitl H
    Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Schweiger H; Ortmeier CJ
    Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    Pupita F; Rotatori P; Frausini G
    Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.